CG
DXCM icon

Caprock Group’s DexCom DXCM Stock Holding History

Caprock Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233K Sell
3,710
-6,847
-65% -$477K 0.01% 1005
2025
Q4 		$701K Buy
+10,557
New +$683K 0.01% 704
2025
Q1 		$310K Sell
4,534
-1,981
-30% -$162K 0.01% 857
2024
Q4 		$507K Buy
6,515
+3,012
+86% +$223K 0.02% 620
2024
Q3 		$235K Sell
3,503
-5,092
-59% -$418K 0.01% 800
2024
Q2 		$975K Buy
8,595
+2,370
+38% +$300K 0.04% 377
2024
Q1 		$863K Sell
6,225
-11,768
-65% -$1.48M 0.05% 272
2023
Q4 		$2.23M Buy
17,993
+382
+2% +$39K 0.14% 114
2023
Q3 		$1.64M Buy
17,611
+480
+3% +$54.1K 0.12% 129
2023
Q2 		$2.2M Buy
17,131
+511
+3% +$61.8K 0.16% 97
2023
Q1 		$1.93M Buy
16,620
+475
+3% +$53.2K 0.15% 107
2022
Q4 		$1.83M Buy
16,145
+54
+0.3% +$5.93K 0.17% 91
2022
Q3 		$1.3M Buy
16,091
+245
+2% +$20.8K 0.12% 122
2022
Q2 		$1.18M Buy
15,846
+590
+4% +$53.8K 0.12% 133
2022
Q1 		$1.95M Buy
15,256
+304
+2% +$33.3K 0.18% 88
2021
Q4 		$2.01M Buy
14,952
+440
+3% +$63.2K 0.17% 89
2021
Q3 		$1.98M Buy
14,512
+276
+2% +$34.8K 0.18% 85
2021
Q2 		$1.52M Buy
14,236
+108
+0.8% +$10.4K 0.14% 115
2021
Q1 		$1.27M Buy
14,128
+180
+1% +$16.9K 0.14% 119
2020
Q4 		$1.29M Sell
13,948
-176
-1% -$15.7K 0.15% 117
2020
Q3 		$1.46M Buy
14,124
+808
+6% +$84.4K 0.2% 94
2020
Q2 		$1.35M Buy
13,316
+980
+8% +$87.7K 0.2% 91
2020
Q1 		$830K Sell
12,336
-3,536
-22% -$220K 0.16% 109
2019
Q4 		$868K Hold
15,872
– – 0.16% 110
2019
Q3 		$592K Hold
15,872
– – 0.12% 138
2019
Q2 		$595K Buy
15,872
+20
+0.1% +$629 0.12% 144
2019
Q1 		$472K Buy
15,852
+36
+0.2% +$1.26K 0.09% 185
2018
Q4 		$474K Hold
15,816
– – 0.11% 161
2018
Q3 		$566K Hold
15,816
– – 0.12% 159
2018
Q2 		$376K Hold
15,816
– – 0.08% 231
2018
Q1 		$293K Hold
15,816
– – 0.06% 283
2017
Q4 		$224K Buy
+15,816
New +$206K 0.04% 395
2017
Q3 		– Sell
-15,600
Closed -$285K – 460
2017
Q2 		$285K Buy
+15,600
New +$288K 0.06% 288
2016
Q3 		– Sell
-15,600
Closed -$309K – 368
2016
Q2 		$309K Buy
+15,600
New +$266K 0.08% 208

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Caprock Group's DXCM Position: Q1 2026 in Review

Caprock Group reduced its DexCom (DXCM) stake by 65% in Q1 2026, selling an estimated $477K and leaving 3,710 shares worth $233K. The position accounts for 0.01% of the portfolio, ranked #1005.

Caprock Group first reported a position in DXCM in Q2 2016 and has held it in 34 quarters since. The position peaked at $2.23M in Q4 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Caprock Group held 3,710 shares of DexCom worth $233K as of Q1 2026.
  • Caprock Group sold 6,847 DexCom shares in Q1 2026, an estimated $477K.
  • DexCom made up 0.01% of Caprock Group's portfolio in Q1 2026, its #1005 holding.
  • Caprock Group first reported a position in DexCom in Q2 2016 and has held it in 34 quarters since.
  • Caprock Group's DexCom position peaked at $2.23M in Q4 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.